25 research outputs found

    Asset Management in Volatile Markets

    Get PDF
    The 27th SUERF Colloquium in Munich in June 2008: New Trends in Asset Management: Exploring the Implications was already topical in the Summer of 2008. The subsequent dramatic events in the Autumn of 2008 made the presentations in Munich even more relevant to investors and bankers that want to understand what happens in their investment universe. In the present SUERF Study, we have collected a sample of outstanding colloquium contributions under the fitting headline: Asset Management in Volatile Markets.derivatives, financial innovation, asset management, finance-growth-nexus; Relative Value Strategy, Pair Trading, Slippage, Implementation Shortfall, Asset Management, Fin4Cast

    Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

    Get PDF
    Genetic influences on psychiatric disorders transcend diagnostic boundaries, suggesting substantial pleiotropy of contributing loci. However, the nature and mechanisms of these pleiotropic effects remain unclear. We performed analyses of 232,964 cases and 494,162 controls from genome-wide studies of anorexia nervosa, attention-deficit/hyper-activity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, and Tourette syndrome. Genetic correlation analyses revealed a meaningful structure within the eight disorders, identifying three groups of inter-related disorders. Meta-analysis across these eight disorders detected 109 loci associated with at least two psychiatric disorders, including 23 loci with pleiotropic effects on four or more disorders and 11 loci with antagonistic effects on multiple disorders. The pleiotropic loci are located within genes that show heightened expression in the brain throughout the lifespan, beginning prenatally in the second trimester, and play prominent roles in neurodevelopmental processes. These findings have important implications for psychiatric nosology, drug development, and risk prediction.Peer reviewe

    THE ABUNDANCE OF PRESOLAR GRAINS IN COMET 81P/WILD 2

    No full text
    We carried out hypervelocity impact experiments in order to test the possibility that presolar grains are preferentially destroyed during impact of the comet 81P/Wild 2 samples into the Stardust Al foil collectors. Powdered samples of the ungrouped carbonaceous chondrite Acfer 094 were shot at 6 km s–1 into Stardust flight spare Al foil. Craters from the Acfer 094 test shots, as well as ones from the actual Stardust cometary foils, were analyzed by NanoSIMS ion imaging to search for presolar grains. We found two O-rich presolar grains and two presolar SiC grains in the Acfer 94 test shots, with measured abundances in the foils of 4 and 5 ppm, respectively, significantly lower than the amount of presolar grains actually present in this meteorite. Based on known abundances of these phases in Acfer 094, we estimate a loss of over 90% of the O-rich presolar grains; the fraction of SiC lost is lower, reflecting its higher resistance to destruction. In the Stardust cometary foils, we identified four O-rich presolar grains in 5000 ?m2 of crater residue. Including a presolar silicate grain found by Leitner et al., the overall measured abundance of O-rich presolar grains in Wild 2 is ~35 ppm. No presolar SiC has been found in the foil searches, although one was identified in the aerogel samples. Based on the known abundances of presolar silicates and oxides in Acfer 094, we can calculate the pre-impact abundances of these grains in the Stardust samples. Our calculations indicate initial abundances of 600-830 ppm for O-rich presolar grains. Assuming a typical diameter of ~300 nm for SiC suggests a presolar SiC abundance of ~45 ppm. Analyses of the Stardust samples indicated early on that recognizable presolar components were not particularly abundant, an observation that was contrary to expectations that the cometary material would, like interplanetary dust particles, be dominated by primitive materials from the early solar system (including abundant presolar grains), which had remained essentially unaltered over solar system history in the cold environment of the Kuiper Belt. Our work shows that comet Wild 2, in fact, does contain more presolar grains than measurements on the Stardust samples suggest, with abundances similar to those observed in primitive IDP

    A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients

    No full text
    INTRODUCTION: Sorafenib has demonstrated single agent activity in non-small cell (NSCLC) and small cell lung cancer (SCLC). Carboplatin/pemetrexed (CbP) and cisplatin/etoposide (PE) are commonly used in the treatment of these diseases. METHODS: A phase I trial escalating doses of sorafenib in combination with fixed doses of PE (Arm A) or CbP (Arm B) was performed using a 3-patient cohort design to determine the maximum tolerated dose (MTD) and dose limiting toxicities (DLT); DLT were assessed in the first cycle. The trial was subsequently amended with closure of Arm B and to include Arm C with a reduced dose of carboplatin. RESULTS: Between 9/2007 and 9/2008, 20 pts were treated on the trial; median age 62 (range 42-73), male/female ratio 12/8, PS 0/1 ratio 6/14, and median number of prior therapies 2 (range 1-4). The most common tumor types were NSCLC and SCLC. On Arm A at dose level 0 (sorafenib 200 mg BID), 2 of 4 patients experienced DLT; 2 patients were enrolled at dose level -1 (sorafenib 200 mg QD) without DLT, but this arm was closed due to slow accrual. On Arm B, 2 of 3 patients experienced DLT at dose level 0 (sorafenib 200 mg BID). On Arm C at dose level 0 (sorafenib 200 mg BID), 1 of 6 patients experienced DLT, and at dose level +1 (sorafenib 400 mg BID) 2 of 5 patients experienced a DLT. CONCLUSIONS: The MTD of sorafenib was 200 mg BID continuously in combination with carboplatin (AUC of 5) and pemetrexed 500 mg/m(2) every 3 weeks. However, only 6 patients were treated at this dose level, and the results should be interpreted cautiously

    <i>Papio</i> Cranium from the Hominin-Bearing Site of Malapa: Implications for the Evolution of Modern Baboon Cranial Morphology and South African Plio-Pleistocene Biochronology

    No full text
    <div><p>A new partial cranium (UW 88-886) of the Plio-Pleistocene baboon <i>Papio angusticeps</i> from Malapa is identified, described and discussed. UW 88-886 represents the only non-hominin primate yet recovered from Malapa and is important both in the context of baboon evolution as well as South African hominin site biochronology. The new specimen may represent the first appearance of modern baboon anatomy and coincides almost perfectly with molecular divergence date estimates for the origin of the modern <i>P</i>. <i>hamadryas</i> radiation. The fact that the Malapa specimen is dated between ~2.026–2.36 million years ago (Ma) also has implications for the biochronology of other South African Plio-Pleistocene sites where <i>P</i>. <i>angusticeps</i> is found.</p></div
    corecore